World of DTC Marketing

JUNE 19, 2025

Critics of direct-to-consumer (DTC) pharma advertising have called for a ban. They argue it misleads patients, drives up drug costs, and pushes people to pressure doctors for drugs they may not need. They’re not wrong about the consequences, but they’re also ignoring a core reality: DTC marketing isn’t going anywhere in the U.S. anytime soon. Why? Because too many influential players benefit from the status quo. 1.

Doctor 254

Doctor Doctors Regulation Marketing 254

Pharmaceutical Technology

JUNE 19, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Clinical Trials 130

Clinical Trials Clinical Trials Manufacturing Trials 130

Rethinking Clinical Trials

JUNE 19, 2025

                        Speakers Stephanie Morain, PhD, MPH Associate Professor, Berman Institute of Bioethics & Department of Health Policy & Management Johns Hopkins University Nancy Kass, ScD Phoebe Berman Professor of Bioethics & Public Health Berman Institute of Bioethics & Department of Health Policy & Management Johns Hopkins University Ruth Faden, PhD, MPH Philip Franklin Wagley Professor of Biomedical Ethics Berman Institute of Bioethics &

Clinical Trials 162

Clinical Trials Clinical Trials Trials Cardiology 162

Scienmag

JUNE 19, 2025

In the rapidly evolving landscape of immunotherapy, researchers have unveiled a strikingly innovative approach that could revolutionize how chimeric antigen receptor (CAR) T cells are generated and deployed to combat cancer and autoimmune diseases. This novel strategy circumvents the traditional, labor-intensive ex vivo manufacturing processes by enabling the generation of CAR T cells directly within the patient’s body.

In-Vivo 52

In-Vivo Engineer Manufacturing DNA 52

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.

Compliance

The Pharma Data

JUNE 19, 2025

Grifols’ BT524 Fibrinogen Therapy Shows Promise in Phase 3 Trial Published in The Lancet’s eClinicalMedicine Grifols , a globally recognized healthcare company and a leader in the production of plasma-derived therapies, has marked a significant advancement in the treatment of acquired fibrinogen deficiency (AFD). The company recently announced the publication of positive Phase 3 clinical trial results for its investigational fibrinogen concentrate, BT524, in eClinicalMedicine , a prestigio

Containment 40

Containment Trials Clinical Trials Clinical Trials 40

Scienmag

JUNE 19, 2025

In a groundbreaking advancement that promises to reshape the landscape of targeted drug delivery, scientists at Xi’an Jiaotong-Liverpool University (XJTLU) in collaboration with Nanjing University have engineered a novel nanoparticle system that significantly enhances the efficiency and safety of administering chemotherapy and potentially other therapeutic agents.

Drug Delivery 72

Drug Delivery Drugs Drug Delivery Systems Protein 72

Scienmag

JUNE 19, 2025

In an era characterized by an unprecedented proliferation of digital data, the fundamental demographic infrastructure that underpins effective governance is experiencing a profound decline. Jessica Espey and colleagues illuminate this escalating crisis in their recent Policy Forum, revealing that accurate population data collection and curation—a critical component for evidence-based policy-making—is faltering worldwide.

Development 69

Development Vaccination Vaccine Research 69

Pharma Times

JUNE 19, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs eXmoor and Signadori Bio enter cell therapy partnership by Emily Kimber | 19th Jun 2025 | News Signadori is advancing a platform designed to overcome the challenges of treating solid cancers eXmoor Pharma and Signadori Bio have entered into a partnership aimed at advancing a gene-modified monocyte-derive

Gene Therapy 120

Gene Therapy FDA Approval Gene Manufacturing 120

Scienmag

JUNE 19, 2025

In a groundbreaking study that reshapes our understanding of the genetic determinants of serum lipid levels, a consortium of international researchers has unveiled novel genetic loci influenced by the complex interplay between genetic variants and psychosocial factors. Published recently in Translational Psychiatry , this multi-ancestry genome-wide association study (GWAS) integrates single nucleotide polymorphism (SNP)-by-psychosocial interaction analyses to reveal previously unidentified genet

Genetics 59

Genetics Genomics Genome Gene 59

pharmaphorum

JUNE 19, 2025

Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back once again

Drugs 66

Drugs 66

Advertisement

Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness

Trials

Scienmag

JUNE 19, 2025

In a landmark advancement that could revolutionize colorectal cancer treatment, researchers have developed a pioneering organoid model derived from colorectal cancer cell lines, embodying stem cell-like characteristics that faithfully replicate the regrowth properties of residual cancer cells following neoadjuvant chemotherapy. This innovative model offers unprecedented insights into the elusive biology of cancer persistence and recurrence, a critical hurdle in effective clinical management of c

In-Vivo 59

In-Vivo Research Gene Expression Genotype 59

Pharmaceutical Technology

JUNE 19, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Licensing 130

Licensing Licensing Manufacturing Clinical Trials 130

Scienmag

JUNE 19, 2025

A groundbreaking new study delves into the intricate cellular communication disruptions underlying post-traumatic stress disorder (PTSD), revealing pivotal changes in brain cell signaling that may redefine how we understand this debilitating condition. Using advanced single-cell transcriptomic analyses, researchers have pinpointed specific alterations in how neurons and glial cells communicate, highlighting the diminished role of somatostatin-expressing interneurons (SST INs) and their synaptic

Gene 52

Gene Research Regulation Hormones 52

Pharmaceutical Technology

JUNE 19, 2025

The FDA has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a pre-exposure prophylaxis (PrEP) against HIV.

Production 165

Production 165

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?

Compliance

Scienmag

JUNE 19, 2025

A recent Cochrane review has substantially advanced our understanding of how virtual reality (VR) can be utilized in stroke rehabilitation, particularly in helping patients recover arm movement. This comprehensive analysis is essential, given that stroke is one of the leading causes of long-term disability worldwide. The incorporation of VR technology has opened new avenues for enhancing rehabilitation outcomes, and the findings of this systematic review underline its value as an adjunct therape

Research 59

Research Development Production Trials 59

XTalks

JUNE 19, 2025

The FDA has approved CSL’s Andembry (garadacimab-gxii) , a first-of-its-kind prophylactic treatment for hereditary angioedema (HAE) that targets factor XIIa (FXIIa). Unlike other therapies, Andembry is approved for once-monthly subcutaneous dosing from the outset for all patients aged 12 and older. What Is HAE? HAE is a rare and potentially life-threatening condition that causes unpredictable attacks of swelling in areas such as the face, abdomen and throat.

FDA Approval 59

FDA Approval Allergies Trials Development 59

Scienmag

JUNE 19, 2025

In the complex landscape of pediatric inflammatory disorders, two conditions—Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C)—have emerged as focal points of scientific inquiry due to their overlapping clinical presentations and the enigmatic roles of immune cells involved in their pathology. Recent insights into neutrophils, the frontline soldiers of the innate immune response, have illuminated their profound heterogeneity and functional diversity, particularly in

Immune Response 64

Immune Response Gene Expression Bioinformatics Regulation 64

PharmTech

JUNE 19, 2025

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

Manufacturing 59

Manufacturing Development Drugs Vaccination 59

Advertisement

Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.

Life Science

Scienmag

JUNE 19, 2025

In recent years, the escalating prevalence of metabolic-associated fatty liver disease (MAFLD) among pediatric populations has emerged as a significant public health concern worldwide. Traditionally considered an adult condition, the rapid rise of MAFLD in children parallels surging rates of obesity, sedentary lifestyles, and unhealthy dietary patterns.

Insulin 59

Insulin Genetics Medicine Research 59

STAT News

JUNE 19, 2025

One of us, Ryan, fights every single day to maintain long-term recovery from a substance use disorder that nearly cost him everything. The other, Teresa, lives with the permanent, aching void left by the loss of her beloved son Spencer at age 24 to a preventable overdose. This loss came after losing her 17-year-old son, Graham, in 2014 shortly after leaving rehab.

124

124

Scienmag

JUNE 19, 2025

The progressive epidemic of non-alcoholic fatty liver disease (NAFLD) and its more aggressive form, non-alcoholic steatohepatitis (NASH), has increasingly drawn the focus of the scientific community due to their direct links with hepatocellular carcinoma (HCC). Central to this pathological progression are regulated cell death pathways, mechanisms of cellular demise intricately tied to disease onset, progression, and potential therapeutic targeting.

Protein 52

Protein Regulation Gene Gene Editing 52

Pharma Marketing Network

JUNE 19, 2025

The intersection of artificial intelligence and pharmaceutical marketing is creating new waves of innovation. In 2025, AI generated marketing campaigns are no longer experimental. They are being deployed to personalize content, predict engagement, and automate outreach. But is the pharma industry truly ready to embrace these capabilities? Table of Contents What Are AI Generated Marketing Campaigns?

Marketing 64

Marketing Compliance Branding Pharma Companies 64

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Scienmag

JUNE 19, 2025

In the ever-evolving realm of neuroscience and cognitive science, a groundbreaking study has emerged that sheds new light on the dynamic nature of human auditory perception. The research, authored by Luthra, Luor, Tierney, and colleagues, reveals how statistical learning—the brain’s remarkable ability to detect and internalize patterns and regularities in sensory input—actively sculpts the way we perceive sounds in real time.

Research 92

Research Development 92

PharmTech

JUNE 19, 2025

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

Manufacturing 59

Manufacturing Life Science Drugs Development 59

Scienmag

JUNE 19, 2025

In a groundbreaking advancement poised to reshape the landscape of sustainable chemical manufacturing, researchers at Colorado State University (CSU) have unveiled an innovative light-driven catalytic process that dramatically enhances the efficiency of transforming fossil fuel derivatives into valuable modern chemicals. This pioneering method, published in Science , harnesses the power of visible light to facilitate super-reducing organic photoredox catalysis at room temperature, a feat that pr

Reagent 98

Reagent Manufacturing Research Contamination 98

BioTech 365

JUNE 19, 2025

CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells In-vitro lab results confirmed that the Company’s cell targeting nanoparticles successfully entered cancer cells and avoided non-cancerous cells Lehi, June … Continue reading →

In-Vitro 52

In-Vitro 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Scienmag

JUNE 19, 2025

In a groundbreaking study published in Science , researchers have illuminated a critical yet overlooked challenge facing aquatic environmental protection: the substantial gaps and limitations in chemical monitoring that significantly hinder the accurate evaluation of ecological risks at large scales. Despite the mounting evidence that chemical pollution poses a dire threat to biodiversity and ecosystem health, current monitoring frameworks fall short when tasked with detecting and characterizing

Contamination 89

Contamination Regulation Research Scientist 89

Pharmaceutical Technology

JUNE 19, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Clinical Trials 130

Clinical Trials Clinical Trials Manufacturing Trials 130

Scienmag

JUNE 19, 2025

A groundbreaking hypothesis emerging from researchers at the Universities of Cambridge and Oxford suggests that the placenta, and specifically the steroid hormones it generates during pregnancy, may have played a decisive role in shaping the evolution of the human brain. This theory not only sheds light on the biological foundations of our cognitive capacities but also provides a fresh perspective on the emergence of social behaviors that have enabled human societies to expand and thrive.

Hormones 59

Hormones Research Development Genetic Analysis 59

STAT News

JUNE 19, 2025

Reliable communication for people with paralysis is nearing reality. Researchers have now demonstrated that a brain-computer interface can reliably translate thoughts into speech, including matching a person’s intended tone and pitch.  It is the second study in as many months to validate the concept’s safety and initial efficacy. The findings are welcome news for a field that has spent decades trying to transform brain activity into reliable communication for people with paral

Research 107

Research 107

Advertisement

Clinical Supply